Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
AIDX20/20 Biolabs, Inc.
| Figure | AIDX20/20 Biolabs, Inc.FY2025 · Dec |
|---|---|
| Revenue | $2.05M |
| Revenue, yoy | +16.7% |
| Net income | $3.74M |
| Net income, yoy | +32.7% |
| Net margin | -182.8% |
| Free cash flow | — |
| FCF margin | — |
| EPS, diluted | $0.76 |
Add another company.
Annual · FY2024–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed